Experience with Omacetaxine for TKI-Resistant TKI CML

preview_player
Показать описание
Javier Pinilla-Ibarz, MD, PhD, and Camille N. Abboud, MD, discuss clinical experience using omacetaxine in chronic and accelerated phase chronic myeloid leukemia.
Рекомендации по теме
visit shbcf.ru